Patents by Inventor Judit Horváth

Judit Horváth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
    Patent number: 10765677
    Abstract: The present disclosure relates to stable formulations of receptor tyrosine kinase inhibitors (TKI), e.g., pazopanib; methods of preparation thereof; and use of the disclosed formulations in sustained delivery of the active agent to a target site. The disclosure further relates to methods of converting one polymorphic Form of a TKI to another polymorphic Form and/or an amorphous form.
    Type: Grant
    Filed: June 7, 2019
    Date of Patent: September 8, 2020
    Assignee: ForSight Vision4, Inc.
    Inventors: Judit Horvath, Irina Astafieva, Signe Erickson, Kathleen Cogan Farinas
  • STABLE AND SOLUBLE FORMULATIONS OF RECEPTOR TYROSINE KINASE INHIBITORS, AND METHODS OF PREPARATION THEREOF
    Publication number: 20190365757
    Abstract: The present disclosure relates to stable formulations of receptor tyrosine kinase inhibitors (TKI), e.g., pazopanib; methods of preparation thereof; and use of the disclosed formulations in sustained delivery of the active agent to a target site. The disclosure further relates to methods of converting one polymorphic Form of a TKI to another polymorphic Form and/or an amorphous form.
    Type: Application
    Filed: June 7, 2019
    Publication date: December 5, 2019
    Inventors: Judit Horvath, Irina Astafieva, Signe Erickson, Kathleen Cogan Farinas
  • Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
    Patent number: 10363255
    Abstract: The present disclosure relates to stable formulations of receptor tyrosine kinase inhibitors (TKI), e.g., pazopanib; methods of preparation thereof; and use of the disclosed formulations in sustained delivery of the active agent to a target site. The disclosure further relates to methods of converting one polymorphic Form of a TKI to another polymorphic Form and/or an amorphous form.
    Type: Grant
    Filed: January 25, 2018
    Date of Patent: July 30, 2019
    Assignee: FORSIGHT VISION4, INC.
    Inventors: Judit Horvath, Irina Astafieva, Signe Erickson, Kathleen Cogan Farinas
  • STABLE AND SOLUBLE FORMULATIONS OF RECEPTOR TYROSINE KINASE INHIBITORS, AND METHODS OF PREPARATION THEREOF
    Publication number: 20180147204
    Abstract: The present disclosure relates to stable formulations of receptor tyrosine kinase inhibitors (TKI), e.g., pazopanib; methods of preparation thereof; and use of the disclosed formulations in sustained delivery of the active agent to a target site. The disclosure further relates to methods of converting one polymorphic Form of a TKI to another polymorphic Form and/or an amorphous form.
    Type: Application
    Filed: January 25, 2018
    Publication date: May 31, 2018
    Inventors: Judit Horvath, Irina Astafieva, Signe Erickson, Kathleen Cogan Farinas
  • Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
    Patent number: 9968603
    Abstract: Therapeutic agent delivery formulations for the sustained release of therapeutic agents from a Port Delivery System (PDS) implant is described in this application.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: May 15, 2018
    Assignee: FORSIGHT VISION4, INC.
    Inventors: Irina Astafieva, Judit Horvath, Kathleen Cogan Farinas, Blaine Bueche, Signe Erickson
  • Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
    Patent number: 9895369
    Abstract: The present disclosure relates to stable formulations of receptor tyrosine kinase inhibitors (TKI), e.g., pazopanib; methods of preparation thereof; and use of the disclosed formulations in sustained delivery of the active agent to a target site. The disclosure further relates to methods of converting one polymorphic Form of a TKI to another polymorphic Form and/or an amorphous form.
    Type: Grant
    Filed: September 20, 2016
    Date of Patent: February 20, 2018
    Assignee: FORSIGHT VISION4, INC
    Inventors: Judit Horvath, Irina Astafieva, Signe Erickson, Kathleen Cogan Farinas
  • STABLE AND SOLUBLE FORMULATIONS OF RECEPTOR TYROSINE KINASE INHIBITORS, AND METHODS OF PREPARATION THEREOF
    Publication number: 20170071938
    Abstract: The present disclosure relates to stable formulations of receptor tyrosine kinase inhibitors (TKI), e.g., pazopanib; methods of preparation thereof; and use of the disclosed formulations in sustained delivery of the active agent to a target site. The disclosure further relates to methods of converting one polymorphic Form of a TKI to another polymorphic Form and/or an amorphous form.
    Type: Application
    Filed: September 20, 2016
    Publication date: March 16, 2017
    Inventors: Judit Horvath, Irina Astafieva, Signe Erickson, Kathleen Cogan Farinas
  • Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
    Patent number: 9474756
    Abstract: The present disclosure relates to stable formulations of receptor tyrosine kinase inhibitors (TKI), e.g., pazopanib; methods of preparation thereof; and use of the disclosed formulations in sustained delivery of the active agent to a target site. The disclosure further relates to methods of converting one polymorphic Form of a TKI to another polymorphic Form and/or an amorphous form.
    Type: Grant
    Filed: August 6, 2015
    Date of Patent: October 25, 2016
    Assignee: ForSight Vision4, Inc.
    Inventors: Judit Horvath, Irina Astafieva, Signe Erickson, Kathleen Cogan Farinas
  • Stable and Soluble Formulations of Receptor Tyrosine Kinase Inhibitors, and Methods of Preparation Thereof
    Publication number: 20160038488
    Abstract: The present disclosure relates to stable formulations of receptor tyrosine kinase inhibitors (TKI), e.g., pazopanib; methods of preparation thereof; and use of the disclosed formulations in sustained delivery of the active agent to a target site. The disclosure further relates to methods of converting one polymorphic Form of a TKI to another polymorphic Form and/or an amorphous form.
    Type: Application
    Filed: August 6, 2015
    Publication date: February 11, 2016
    Inventors: Judit Horvath, Irina Astafieva, Signe Erickson, Kathleen Cogan Farinas
  • Systems for Sustained Intraocular Delivery of Low Solubility Compounds from a Port Delivery System Implant
    Publication number: 20140276482
    Abstract: Therapeutic agent delivery formulations for the sustained release of therapeutic agents from a Port Delivery System (PDS) implant is described in this application.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Inventors: Irina Astafieva, Judit Horvath, Kathleen Cogan Farinas, Blaine Bueche, Signe Erickson
  • Process for the preparation of 17-hydroxy-6?,7?;15?,16?-bismethylene-17?-pregn-4-ene-3-one-21-carboxylic acid ?-lactone and key intermediates for this process
    Patent number: 8450476
    Abstract: The invention relates to a process for the preparation of 17-hydroxy-6?,7?;15?,16?-bismethylene-17?-pregn-4-ene-3-one-21-carboxylic acid ?-lactone of formula (I) as well as to key-intermediates for this process.
    Type: Grant
    Filed: October 11, 2005
    Date of Patent: May 28, 2013
    Assignee: Richter Gedeon Nyrt.
    Inventors: György Gálik, Judit Horváth, Béla Sörös, Sándor Mahö, Zoltán Tuba, Gábor Balogh
  • Industrial process for the preparation of 17-hydroxy-6beta,7beta;15beta, 16beta-bismethylene-3-oxo-17alpha-pregn-4-ene-21-carboxylic acid y-lactone and key intermediates for this process
    Patent number: 8309712
    Abstract: The invention relates to an industrial process for the preparation of 17-hydroxy-6?,7?;15?,16?-bismethylene-3-oxo-17?-pregn-4-ene-21-carboxylic acid ?-lactone of formula (I), and to the key-intermediates for this process.
    Type: Grant
    Filed: October 11, 2005
    Date of Patent: November 13, 2012
    Assignee: Richter Gedeon Nyrt.
    Inventors: Béla Sörös, Judit Horváth, György Gálik, József Bódi, Zoltán Tuba, Sándor Mahó, Gábor Balogh, Antal Aranyi
  • Industrial Process for the Preparation of 17-Hydroxy-6Beta, 7Beta; 15Beta, 16Beta-Bismethylene-3-Oxo-17Alpha-Pregn-4-Ene-21-Carboxylic Acid Y-Lactone and Key Intermediates for this Process
    Publication number: 20080200668
    Abstract: The invention relates to an industrial process for the preparation of 17-hydroxy-6?,7?;15?,16?-bismethylene-3-oxo-17?-pregn-4-ene-21-carboxylic acid ?-lactone of formula (I), and to the key-intermediates for this process.
    Type: Application
    Filed: October 11, 2005
    Publication date: August 21, 2008
    Inventors: Bela Soros, Judit Horvath, Gyorgy Galik, Jozsef Bodi, Zoltan Tuba, Sandor Maho, Gabor Balogh, Antal Aranyi
  • Process for the Preparation of 17-Hydroxy-6Beta, 7Beta; 15Beta, 16Beta-Bismethylene- 17Alpha-Pregn-4-Ene-3-One-21-Carboxylic Acid Y-Lactone and Key Intermediates for this Process
    Publication number: 20080194812
    Abstract: The invention relates to a process for the preparation of 17-hydroxy-6?,7?;15?,16?-bismethylene-17?-pregn-4-ene-3-one-21-carboxylic acid ?-lactone of formula (I) as well as to key-intermediates for this process.
    Type: Application
    Filed: October 11, 2005
    Publication date: August 14, 2008
    Inventors: Gyorgy Galik, Judit Horvath, Bela Soros, Sandor Maho, Zoltan Tuba, Gabor Balogh
  • Process for the preparation of pharmaceutical compositions possessing neurogenic or non-neurogenic anti-inflammatory as well as analgetic effects
    Publication number: 20010009899
    Abstract: The invention relates to the use of peptide amides of formula (I) 1
    Type: Application
    Filed: January 5, 2001
    Publication date: July 26, 2001
    Inventors: Gyorgy Keri, Janos Szolcsanyi, Erika Pinter, Zsuzsanna Helyes, Judit Erchegyi, Aniko Horvath, Judit Horvath, Istvan Teplan, Laszlo Orfi
  • Tumor growth-inhibiting somatostatin analogues, pharmaceutical compositions containing them and process for preparing same
    Patent number: 5480870
    Abstract: The invention relates to tumor-inhibiting heptapeptide and octapeptide amide derivatives and to a method of treating mammals, including men, suffering from tumors or from the excessive secretion of insulin, glucagon or growth hormone using these compounds.
    Type: Grant
    Filed: April 26, 1994
    Date of Patent: January 2, 1996
    Assignee: Biosignal Kutato-Fejlesztokft
    Inventors: Gyorgy Keri, Imre Mezo, Aniko Horvath, Zsolt Vadasz, Istvan Teplan, Agnes Balogh, Orsolya Csuka, Gyongyi Bokonyi, Balas Szoke, Judit Horvath, Miklos Idei, Janos Seprodi
  • Diamino-androstane derivatives
    Patent number: 5410040
    Abstract: New monoquaternary and diquaternary 5-alpha-hydroxy-3,16-diaminoandrostane salts are disclosed with curare-like muscle relaxant activity. The new salts are characterized by a surprisingly rapid onset time.
    Type: Grant
    Filed: June 27, 1986
    Date of Patent: April 25, 1995
    Assignee: Richter Gedeon Vegyeszeti Gyar Rt.
    Inventors: Zoltan Tuba, Judit Horvath, Maria Lovas nee Marsai, Miklos Riesz, deceased, Katalin Biro, Laszle Szporny, Egon Karpati
  • Analogs of growth hormone releasing factor (GRF) and a method for the preparation thereof
    Patent number: 5023322
    Abstract: The invention relates to new peptides of the formula ##STR1## wherein R.sup.2 represents Ala or D-Ala,R.sup.11 represents Arg or D-Arg,R.sup.13 represents Val or Ile,R.sup.15 represents Gly, Leu, Phe or a valence bond,R.sup.27 represents Met or Nle,R.sup.28 represents Ser, D-Ser or Asn, andY represents OH or NH.sub.2,and to salts thereof. These compounds stimulate the release of growth hormone and can be used in the therapy as well as for veterinary or animal husbandry purposes.
    Type: Grant
    Filed: August 30, 1989
    Date of Patent: June 11, 1991
    Assignee: MTA Kutatas-es Szervezetelemzo Intezete
    Inventors: Magdolna Kovacs, Judit Horvath, Sandor Vigh, Imre Mezo, Istvan Teplan, Balazs Szoke, Janos Seprodi, Zsolt Vadasz, Edit Hegedus, Gabor Makara, Gyorgy Rappay